[go: up one dir, main page]

AU2017904360A0 - Dosage Regime for Treatment of Kidney Disease - Google Patents

Dosage Regime for Treatment of Kidney Disease

Info

Publication number
AU2017904360A0
AU2017904360A0 AU2017904360A AU2017904360A AU2017904360A0 AU 2017904360 A0 AU2017904360 A0 AU 2017904360A0 AU 2017904360 A AU2017904360 A AU 2017904360A AU 2017904360 A AU2017904360 A AU 2017904360A AU 2017904360 A0 AU2017904360 A0 AU 2017904360A0
Authority
AU
Australia
Prior art keywords
treatment
kidney disease
dosage regime
regime
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2017904360A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dimerix Bioscience Pty Ltd
Original Assignee
Dimerix Bioscience Pty Ltd
Filing date
Publication date
Application filed by Dimerix Bioscience Pty Ltd filed Critical Dimerix Bioscience Pty Ltd
Publication of AU2017904360A0 publication Critical patent/AU2017904360A0/en
Withdrawn legal-status Critical Current

Links

AU2017904360A 2017-10-27 Dosage Regime for Treatment of Kidney Disease Withdrawn AU2017904360A0 (en)

Publications (1)

Publication Number Publication Date
AU2017904360A0 true AU2017904360A0 (en) 2017-11-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP3212233A4 (en) Combination therapy for treatment of disease
ZA201806819B (en) Pharmaceutical combinations for the treatment of cancer
EP3256218A4 (en) Kdm1a inhibitors for the treatment of disease
EP3448874A4 (en) Compositions for the treatment of disease
EP3448987A4 (en) Compositions for the treatment of disease
EP3261713A4 (en) Blood pump for treatment of bradycardia
SG11202104923YA (en) Pharmaceutical combination for treatment of cancer
EP3148532A4 (en) Pharmaceutical combination for the treatment of cancer
EP3103466A4 (en) Preventive or therapeutic agent for kidney disease
EP3304076A4 (en) Methods for determining drug efficacy for treatment of cancer using ratios of cereblon associated proteins
EP3340974A4 (en) Methods for treatment of diseases
EP3289084A4 (en) siRNA INHIBITION OF HUMAN ANTIGEN R EXPRESSION FOR TREATMENT OF CANCER
IL261278A (en) Pharmaceutical compositions for the treatment of cancer
EP3471775A4 (en) Hemoglobin-targeted drug delivery for the treatment of cancer
IL281782A (en) Pharmaceutical combination for the treatment of cancer
EP3253379A4 (en) Pharmaceutical composition for the treatment of obesity
AU2017904360A0 (en) Dosage Regime for Treatment of Kidney Disease
AU2017902795A0 (en) Dosage Regime for Treatment of Kidney Disease
AU2017902717A0 (en) Dosage Regime for Treatment of Kidney Disease
AU2018902690A0 (en) Dosage Regime for Treatment of Kidney Disease
HK40120326A (en) A pharmaceutical combination for the treatment of a cancer
HK40107360A (en) Pharmaceutical composition for the treatment of cancer
HK40070316B (en) Heterocyclic compounds for the treatment of disease
HK40027652A (en) Treatment of neuroinflammatory disease
HK40049516A (en) Kdm1a inhibitors for the treatment of disease